Simvotin 10/20/40 10/20/40 mg Tablets
PDF Leaflet Revision Date: 03 May 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Management of hypercholesterolaemia and coronary heart disease.
Dosage (summary)
Starting dose 10 mg/day in the evening; max 80 mg/day.
Special Populations
- Renal impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- CYP3A4 inhibitors
- Gemfibrozil
- Ciclosporin
Contraindications
- Hypersensitivity
- Liver disease
- Pregnancy
- Breastfeeding
Common side effects
- Myopathy
- Muscle cramps
- Headache
- Dizziness
Counselling Points
- Report unexplained muscle pain
- Avoid grapefruit juice
- Monitor blood glucose levels
Serious warnings
- Risk of myopathy/rhabdomyolysis
- Liver function monitoring required
Important Disclaimer
The Simvotin 10/20/40 10/20/40 mg Tablets professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
